NVRO - Nevro Corp Stock Price, Fair Value and News

11.41USD+0.24 (+2.15%)Market Closed

Market Summary

USD11.41+0.24

Market Closed

2.15%

NVRO Alerts

Losses in recent quarter

NVRO Stock Price

View Fullscreen

NVRO RSI Chart

NVRO Valuation

Market Cap

419.1M

Price/Earnings (Trailing)

-5.07

Price/Sales (Trailing)

0.97

EV/EBITDA

-8

Price/Free Cashflow

-5.9

NVRO Price/Sales (Trailing)

NVRO Profitability

Operating Margin

76.19%

EBT Margin

-20.47%

Return on Equity

-29.65%

Return on Assets

-13.86%

Free Cashflow Yield

-16.93%

NVRO Fundamentals

NVRO Revenue

Revenue (TTM)

430.7M

Rev. Growth (Yr)

5.78%

Rev. Growth (Qtr)

-12.29%

NVRO Earnings

Earnings (TTM)

-82.6M

Earnings Growth (Yr)

27.46%

Earnings Growth (Qtr)

-182.92%

Breaking Down NVRO Revenue

Last 7 days

16.6%

Last 30 days

-7.2%

Last 90 days

-34.1%

Trailing 12 Months

-58.2%

How does NVRO drawdown profile look like?

NVRO Financial Health

Current Ratio

7.38

Debt/Equity

0.77

Debt/Cashflow

-0.29

NVRO Investor Care

Shares Dilution (1Y)

2.54%

Diluted EPS (TTM)

-2.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	430.7M	0	0	0
2023	414.9M	419.4M	422.8M	425.2M
2022	386.1M	388.0M	395.3M	406.4M
2021	363.2M	409.1M	393.9M	386.9M
2020	395.6M	358.4M	366.7M	362.0M
2019	381.8M	379.3M	383.8M	390.3M
2018	345.9M	363.9M	377.3M	387.3M
2017	255.3M	277.9M	299.2M	326.7M
2016	101.6M	145.6M	191.1M	228.5M
2015	35.6M	39.5M	46.2M	69.6M
2014	24.8M	26.6M	29.1M	32.6M
2013	19.5M	20.8M	22.2M	23.5M
2012	0	0	0	18.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Nevro Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 24, 2024	thornal kevin r	sold (taxes)	-303,155	12.51	-24,233	president & ceo
Apr 11, 2024	grossman d keith	sold (taxes)	-52,296	13.12	-3,986	-
Apr 04, 2024	rashid kashif	sold (taxes)	-6,327	13.21	-479	svp, corp dev and clo
Mar 31, 2024	demane michael f	acquired	-	-	1,817	-
Mar 31, 2024	weatherman elizabeth h	acquired	-	-	1,372	-
Mar 31, 2024	fischer frank m	acquired	-	-	1,159	-
Mar 31, 2024	kosaraju sridhar	acquired	-	-	1,090	-
Mar 11, 2024	grossman d keith	sold (taxes)	-32,738	14.99	-2,184	-
Mar 07, 2024	siller greg	acquired	-	-	75,893	chief commercial officer
Mar 07, 2024	rashid kashif	sold (taxes)	-107,929	15.32	-7,045	general counsel

Which funds bought or sold NVRO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	reduced	-12.68	-1,754,830	2,482,930	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-13.29	-342,061	475,957	-%
May 16, 2024	COMERICA BANK	sold off	-100	-280	-	-%
May 15, 2024	JANUS HENDERSON GROUP PLC	added	0.01	-105,091	213,711	-%
May 15, 2024	D. E. Shaw & Co., Inc.	reduced	-4.09	-9,228,240	16,660,000	0.01%
May 15, 2024	Point72 Asset Management, L.P.	new	-	62,092	62,092	-%
May 15, 2024	Bellevue Group AG	reduced	-31.47	-2,293,620	1,952,790	0.03%
May 15, 2024	QUADRANT CAPITAL GROUP LLC	added	89.71	1,029	4,795	-%
May 15, 2024	Bridgefront Capital, LLC	new	-	153,959	153,959	0.12%
May 15, 2024	Point72 Asia (Singapore) Pte. Ltd.	new	-	94,770	94,770	0.03%

Are Funds Buying or Selling NVRO?

Are funds buying NVRO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NVRO

No. of Funds

NVRO Alerts

Losses in recent quarter

Unveiling Nevro Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 21, 2024	engaged capital llc	6.0%	2,168,163	SC 13D/A
Feb 14, 2024	armistice capital, llc	8.76%	3,176,000	SC 13G
Feb 14, 2024	arrowmark colorado holdings llc	8.30%	3,011,059	SC 13G
Feb 14, 2024	alger associates inc	5.8%	2,115,664	SC 13G
Feb 13, 2024	vanguard group inc	11.23%	4,067,271	SC 13G/A
Jan 24, 2024	blackrock inc.	9.3%	3,374,031	SC 13G/A
Dec 11, 2023	engaged capital llc	6.0%	2,168,163	SC 13D
Sep 11, 2023	fmr llc	-	0	SC 13G/A
Jun 12, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	0.7%	280,434	SC 13G/A

Recent SEC filings of Nevro Corp

View All Filings

Date Filed	Form Type	Document
May 17, 2024	3	Insider Trading
May 09, 2024	8-K	Current Report
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Apr 26, 2024	4	Insider Trading
Apr 25, 2024	8-K	Current Report
Apr 15, 2024	4	Insider Trading
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 08, 2024	4	Insider Trading

Peers (Alternatives to Nevro Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Nevro Corp News

Latest updates

Nevro Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-12.3%	101,899,000	116,176,000	103,862,000	108,809,000	96,327,000	113,844,000	100,466,000	104,213,000	87,842,000	102,760,000	93,205,000	102,330,000	88,610,000	109,731,000	108,460,000	56,390,000	87,467,000	114,374,000	100,162,000	93,571,000	82,148,000
Gross Profit	-12.2%	71,528,000	81,477,000	69,516,000	74,443,000	64,624,000	75,239,000	69,302,000	72,734,000	59,092,000	69,132,000	64,630,000	69,986,000	62,294,000	78,028,000	76,077,000	35,250,000	60,547,000	81,258,000	69,940,000	63,943,000	53,209,000
Operating Expenses	-	107,362,000	-	95,075,000	100,082,000	100,947,000	94,597,000	-12,780,000	96,525,000	91,861,000	95,347,000	111,074,000	85,749,000	84,806,000	78,903,000	79,626,000	70,611,000	83,614,000	92,939,000	85,924,000	90,503,000	95,463,000
S&GA Expenses	9.6%	88,326,000	80,598,000	81,152,000	86,762,000	86,192,000	80,650,000	78,190,000	83,973,000	79,325,000	82,638,000	79,521,000	73,880,000	73,272,000	67,073,000	68,512,000	60,167,000	71,402,000	76,006,000	72,905,000	75,573,000	81,328,000
R&D Expenses	19.4%	14,828,000	12,420,000	13,923,000	13,320,000	14,755,000	13,947,000	14,030,000	12,552,000	12,536,000	12,709,000	11,553,000	11,869,000	11,534,000	11,830,000	11,114,000	10,444,000	12,212,000	16,933,000	13,019,000	14,930,000	14,135,000
EBITDA Margin	19.2%	-0.16	-0.20	-0.21	0.04	0.04	0.04	0.02	-0.32	-0.30	-0.27	-0.20	-0.09	-	-	-	-	-	-	-	-	-
Interest Expenses	105.8%	6,512,000	3,165,000	1,618,000	1,618,000	1,613,000	1,613,000	1,608,000	1,608,000	1,603,000	3,810,000	3,688,000	5,704,000	6,547,000	6,495,000	6,363,000	6,122,000	2,826,000	2,778,000	2,755,000	2,710,000	2,688,000
Income Taxes	105.8%	382,000	-6,578,000	130,000	477,000	325,000	356,000	485,000	241,000	181,000	-78,000	72,000	198,000	342,000	310,000	208,000	44,000	306,000	481,000	420,000	358,000	340,000
Earnings Before Taxes	-60.9%	-25,027,000	-15,559,000	-23,349,000	-24,247,000	-34,704,000	-18,836,000	81,993,000	-24,749,000	-34,144,000	-30,212,000	-50,003,000	-21,392,000	-29,219,000	-6,819,000	-9,777,000	-41,019,000	-24,582,000	-13,261,000	-17,427,000	-27,663,000	-43,736,000
EBT Margin	11.1%	-0.20	-0.23	-0.24	0.01	0.01	0.01	-0.02	-0.36	-0.35	-0.34	-0.27	-0.16	-	-	-	-	-	-	-	-	-
Net Income	-182.9%	-25,409,000	-8,981,000	-23,479,000	-24,724,000	-35,029,000	-19,192,000	81,508,000	-24,990,000	-34,325,000	-30,134,000	-50,075,000	-21,590,000	-29,561,000	-7,129,000	-9,985,000	-41,063,000	-24,888,000	-13,742,000	-17,847,000	-28,021,000	-44,076,000
Net Income Margin	11.6%	-0.19	-0.22	-0.24	0.01	0.01	0.01	-0.02	-0.36	-0.35	-0.34	-0.28	-0.17	-	-	-	-	-	-	-	-	-
Free Cashflow	-228.7%	-35,449,000	-10,785,000	-8,026,000	-16,710,000	-31,902,000	-15,810,000	77,237,000	-14,269,000	-30,025,000	-16,889,000	-19,037,000	-8,869,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-6.2%	596	636	562	570	574	602	606	524	533	575	582	600	776	789	778	753	460	470	448	448	458
Current Assets	-7.2%	493	531	522	531	535	563	566	483	490	531	539	557	739	753	742	717	414	422	401	401	410
Cash Equivalents	-13.4%	90.00	104	65.00	65.00	64.00	120	131	109	49.00	35.00	81.00	146	87.00	45.00	119	277	136	65.00	49.00	63.00	41.00
Inventory	1.8%	121	119	122	120	113	100	99.00	94.00	91.00	94.00	92.00	86.00	86.00	83.00	84.00	92.00	93.00	92.00	91.00	92.00	93.00
Net PPE	0.6%	25.00	25.00	24.00	24.00	23.00	22.00	21.00	21.00	21.00	21.00	20.00	19.00	15.00	14.00	12.00	11.00	11.00	12.00	12.00	12.00	12.00
Goodwill	0.4%	38.00	38.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	-7.3%	318	343	276	275	273	279	281	294	292	271	263	241	409	401	399	379	245	253	250	246	244
Current Liabilities	-19.9%	67.00	83.00	80.00	78.00	75.00	79.00	80.00	73.00	70.00	82.00	75.00	74.00	246	239	239	221	61.00	71.00	68.00	66.00	65.00
Short Term Borrowings	-	-	-	-	-	-	-	-	-	-	-	-	-	171	169	167	164	-	-	-	-	-
Long Term Debt	1.6%	215	211	188	187	187	187	187	186	186	34.00	149	146	144	142	140	137	162	160	158	156	154
LT Debt, Non Current	-100.0%	-	211	188	187	187	187	187	186	186	34.00	149	146	144	142	140	137	162	160	158	156	154
Shareholder's Equity	-5.0%	279	293	286	295	301	324	325	230	240	304	319	358	366	388	380	374	215	216	198	202	214
Retained Earnings	-3.6%	-724	-699	-690	-666	-642	-607	-588	-669	-644	-624	-594	-543	-522	-492	-485	-475	-434	-409	-396	-378	-350
Additional Paid-In Capital	1.2%	1,004	993	978	964	945	934	918	903	886	928	913	902	888	881	865	851	651	626	595	580	565
Shares Outstanding	0.9%	37.00	36.00	36.00	36.00	36.00	36.00	35.00	35.00	35.00	35.00	35.00	35.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	896	-	-	-	1,521	-	-	-	5,695	-	-	-	4,009	-	-	-	1,923	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-266.0%	-32,656	-8,923	-6,090	-14,502	-29,314	-13,423	79,350	-12,834	-28,418	-15,159	-15,362	-4,489	-6,871	11,859	11,336	-16,823	-5,181	-13,475	-3,373	-11,670	-21,707
Share Based Compensation	-5.7%	12,837	13,617	13,523	16,166	13,560	14,807	15,206	13,377	13,408	11,459	12,637	11,034	9,237	10,118	13,965	10,083	8,489	10,382	11,192	9,721	10,402
Cashflow From Investing	2375.1%	25,322	-1,113	7,283	11,274	-24,648	458	-56,504	70,269	50,067	-34,232	-48,185	233,790	50,342	-92,111	-170,131	-167,920	60,294	7,646	-12,538	27,881	9,341
Cashflow From Financing	-113.3%	-6,480	48,698	-1,013	4,122	-2,273	1,374	37.00	2,885	-6,753	3,276	-1,325	-169,862	-1,470	5,139	761	324,827	16,178	21,389	3,009	5,921	1,774

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NVRO Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Income Statement [Abstract]

Revenue

$ 101,899

$ 96,327

Cost of revenue

^[1]

30,371

31,703

Gross profit

71,528

64,624

Operating expenses

Research and development

14,828

14,755

Sales, general and administrative

88,326

86,192

Amortization of intangibles

737

Change in fair value of contingent consideration

3,471

Total operating expenses

107,362

100,947

Income (Loss) from operations

(35,834)

(36,323)

Interest income

3,780

3,278

Interest expense

(6,512)

(1,613)

Change in fair market value of warrants

13,560

Other income (expense), net

(21)

(46)

Loss before income taxes

(25,027)

(34,704)

Provision for income taxes

382

325

Net loss

(25,409)

(35,029)

Other comprehensive income (loss):

Changes in foreign currency translation adjustment

(255)

506

Changes in unrealized gains on short-term investments, net

(526)

587

Net change in other comprehensive income (loss)

(781)

1,093

Comprehensive loss

$ (26,190)

$ (33,936)

Net loss per share, basic

$ (0.7)

$ (0.98)

Net loss per share, diluted

$ (0.7)

$ (0.98)

Weighted average number of shares used to compute basic net loss per share

36,467,371

35,584,685

Weighted average number of shares used to compute diluted net loss per share

36,467,371

35,584,685

[1]	Exclusive of amortization of intangible assets, which is shown separately.

NVRO Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 90,303	$ 104,217
Short-term investments	191,180	218,506
Accounts receivable, net of allowance for doubtful accounts of $1,128 and $1,048 at March 31, 2024 and December 31, 2023, respectively	76,918	79,377
Inventories	120,789	118,676
Prepaid expenses and other current assets	13,414	10,145
Total current assets	492,604	530,921
Property and equipment, net	24,708	24,568
Operating lease assets	7,764	8,944
Goodwill	38,324	38,164
Intangible assets, net	26,617	27,354
Other assets	5,427	5,156
Restricted cash	606	606
Total assets	596,050	635,713
Current liabilities
Accounts payable	21,208	22,520
Accrued liabilities	39,486	45,297
Contingent liabilities, current portion	220	9,836
Other current liabilities	5,860	5,722
Total current liabilities	66,774	83,375
Long-term debt	214,763	211,471
Long-term operating lease liabilities	3,136	4,634
Contingent liabilities, non-current portion	15,564	12,257
Warrant liability	15,179	28,739
Other long-term liabilities	2,093	2,092
Total liabilities	317,509	342,568
Commitments and contingencies (Note 6)
Stockholders’ equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized at March 31, 2024 and December 31, 2023; zero shares issued and outstanding at March 31, 2024 and December 31, 2023
Common stock, $0.001 par value, 290,000,000 shares authorized at March 31,2024 and December 31, 2023; 37,369,746 and 37,044,390 shares issued at March 31, 2024 and December 31, 2023, respectively; 36,686,830 and 36,361,474 shares outstanding at March 31, 2024 and December 31, 2023, respectively	36	36
Additional paid-in capital	1,004,348	992,762
Accumulated other comprehensive income (loss)	(1,024)	(243)
Accumulated deficit	(724,819)	(699,410)
Total stockholders’ equity	278,541	293,145
Total liabilities and stockholders’ equity	$ 596,050	$ 635,713

About Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

CEO	Mr. Kevin R. Thornal
WEBSITE	https://nevro.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1087

Nevro Corp Frequently Asked Questions

What is the ticker symbol for Nevro Corp? What does NVRO stand for in stocks?

NVRO is the stock ticker symbol of Nevro Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nevro Corp (NVRO)?

As of Fri May 17 2024, market cap of Nevro Corp is 419.07 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVRO stock?

You can check NVRO's fair value in chart for subscribers.

What is the fair value of NVRO stock?

You can check NVRO's fair value in chart for subscribers. The fair value of Nevro Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nevro Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NVRO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nevro Corp a good stock to buy?

The fair value guage provides a quick view whether NVRO is over valued or under valued. Whether Nevro Corp is cheap or expensive depends on the assumptions which impact Nevro Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVRO.

What is Nevro Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NVRO's PE ratio (Price to Earnings) is -5.07 and Price to Sales (PS) ratio is 0.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVRO PE ratio will change depending on the future growth rate expectations of investors.